Search

Your search keyword '"Akiyama E"' showing total 16 results
Start Over Author "Akiyama E" Journal european heart journal
16 results on '"Akiyama E"'

2. Inflammation-frailty linkage and its long-term prognostic impact in patients with acute coronary syndrome

Author

Satou, R, primary, Matsuzawa, Y, additional, Akiyama, E, additional, Konishi, M, additional, Yoshii, T, additional, Nakahashi, H, additional, Minamimoto, Y, additional, Okada, K, additional, Maejima, N, additional, Iwahashi, N, additional, Hibi, K, additional, Kosuge, M, additional, Ebina, T, additional, Tamura, K, additional, and Kimura, K, additional

Published
2021
Full Text
View/download PDF

3. Clinical significance of late diastolic tissue doppler parameters after onset of STEMI: from the view point of the timing of the echocardipography

Author

Iwahashi, N, primary, Kirigaya, J, additional, Horii, M, additional, Abe, T, additional, Akiyama, E, additional, Okada, K, additional, Matsuzawa, Y, additional, Maejima, N, additional, Hibi, K, additional, Kosuge, M, additional, Ebina, T, additional, Tamura, K, additional, and Kimura, K, additional

Published
2020
Full Text
View/download PDF

10. 4939Clinical significance of global strain estimated by 3D speckle tracking acutely after onset of ST-elevation myocardial infarction on prediction of long term prognosis

Author

Iwahashi, N, primary, Kirigaya, J K, additional, Horii, M H, additional, Akiyama, E A, additional, Okada, K O, additional, Matsuzawa, Y M, additional, Konishi, M K, additional, Maejima, N M, additional, Hibi, K H, additional, Kosuge, M K, additional, Ebina, T E, additional, Tamura, K T, additional, and Kimura, K K, additional

Published
2019
Full Text
View/download PDF

12. P6354Decreased beneficial effects of oral heart failure medications in patients with acute decompensated heart failure and hyperglycemia: results from an international observational cohort

Author

Akiyama, E, primary, Cinotti, R, additional, Arrigo, M, additional, Lassus, J, additional, Miro, O, additional, Celutkiene, J, additional, Cohen-Solal, A, additional, Maggioni, A P, additional, Mueller, C, additional, Parenica, J, additional, Spinar, J, additional, Sato, N, additional, Tamura, K, additional, Kimura, K, additional, and Mebazaa, A, additional

Published
2019
Full Text
View/download PDF

15. P163Characteristics and prognostic impact of muscle wasting and fat mass in heart failure with preserved ejection fraction

Author

Konishi, M., primary, Akiyama, E., additional, Matsuzawa, Y., additional, Kawashima, C., additional, Sato, R., additional, Nakahashi, H., additional, Minamimoto, Y., additional, Kimura, Y., additional, Maejima, N., additional, Iwahashi, N., additional, Hibi, K., additional, Kosuge, M., additional, Ebina, T., additional, Kimura, K., additional, and Tamura, K., additional

Published
2017
Full Text
View/download PDF

16. The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions.

Author

Motiejūnaitė J, Akiyama E, Cohen-Solal A, Maggioni AP, Mueller C, Choi DJ, Kavoliūnienė A, Čelutkienė J, Parenica J, Lassus J, Kajimoto K, Sato N, Miró Ò, Peacock WF, Matsue Y, Voors AA, Lam CSP, Ezekowitz JA, Ahmed A, Fonarow GC, Gayat E, Regitz-Zagrosek V, and Mebazaa A

Subjects
Acute Disease, Asia, Europe epidemiology, Female, Humans, Male, Prognosis, Prospective Studies, Registries, Stroke Volume, Heart Failure, Ventricular Function, Left
Abstract

Aims: Recent data from national registries suggest that acute heart failure (AHF) outcomes might vary in men and women, however, it is not known whether this observation is universal. The aim of this study was to evaluate the association of biological sex and 1-year all-cause mortality in patients with AHF in various regions of the world., Methods and Results: We analysed several AHF cohorts including GREAT registry (22 523 patients, mostly from Europe and Asia) and OPTIMIZE-HF (26 376 patients from the USA). Clinical characteristics and medication use at discharge were collected. Hazard ratios (HRs) for 1-year mortality according to biological sex were calculated using a Cox proportional hazards regression model with adjustment for baseline characteristics (e.g. age, comorbidities, clinical and laboratory parameters at admission, left ventricular ejection fraction). In the GREAT registry, women had a lower risk of death in the year following AHF [HR 0.86 (0.79-0.94), P < 0.001 after adjustment]. This was mostly driven by northeast Asia [n = 9135, HR 0.76 (0.67-0.87), P < 0.001], while no significant differences were seen in other countries. In the OPTIMIZE-HF registry, women also had a lower risk of 1-year death [HR 0.93 (0.89-0.97), P < 0.001]. In the GREAT registry, women were less often prescribed with a combination of angiotensin-converting enzyme inhibitors and beta-blockers at discharge (50% vs. 57%, P = 0.001)., Conclusion: Globally women with AHF have a lower 1-year mortality and less evidenced-based treatment than men. Differences among countries need further investigation. Our findings merit consideration when designing future global clinical trials in AHF., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.)

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results